Minor
Dalpiciclib an'd Letrozole Combined With Anlotinib Neoadjuvant Therapy in Stage II-III Postmenopausal HR+/HER2- Early Breast Cancer
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Liu ShuNot applicable NCT06605690 Registry history of NCT06605690 on ClinicalTrials.gov (opens the registry)
Changed